SCALABLE MATRIX FOR THE IN VIVO CULTIVATION OF BONE AND CARTILAGE

• US 20110076316A1
• Filed: 10/08/2007
• Published: 03/31/2011
• Est. Priority Date: 10/08/2007
• Status: Abandoned Application

• Current Assignee: Eugene Sherry, Krish Gopalakrishnan, Patrick Hans Warnke, Sureshan Sivananthan
• Original Assignee: Eugene Sherry, Krish Gopalakrishnan, Patrick Hans Warnke, Sureshan Sivananthan
• Inventors: Gopalakrishnan, Krish, Sherry, Eugene, Sivananthan, Sureshan, Warnke, Patrick Hans
• Application Number:
  US12/682,218
• Publication Number:
  US 20110076316A1
• Time in Patent Office: Days
• US Class Current: 424/423
• CPC Class Codes: A61F 2/28 Bones joints A61F2/30
• CPC Class Codes: A61F 2/30907 Nets or sleeves applied to surface of prostheses or in cement
• CPC Class Codes: A61F 2002/2817 Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
• CPC Class Codes: A61F 2002/2835 Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
• CPC Class Codes: A61F 2002/30092 using shape memory or superelastic materials, e.g. nitinol
• CPC Class Codes: A61F 2002/3028 polyhedral different from parallelepipedal and pyramidal
• CPC Class Codes: A61F 2002/3092 having an open-celled or open-pored structure
• CPC Class Codes: A61F 2002/3097 using laser
• CPC Class Codes: A61F 2002/30985 using three dimensional printing [3DP]
• CPC Class Codes: A61F 2210/0014 using shape memory or superelastic materials, e.g. nitinol
• CPC Class Codes: A61F 2230/0063 Three-dimensional shapes
• CPC Class Codes: A61F 2310/00011 Metals or alloys
• CPC Class Codes: A61F 2310/00179 Ceramics or ceramic-like structures
• CPC Class Codes: A61F 2310/00329 Glasses, e.g. bioglass
• CPC Class Codes: A61P 19/02 for joint disorders, e.g. arthritis, arthrosis
• CPC Class Codes: A61P 19/08 for bone diseases, e.g. rachitism, Paget's disease
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The present invention provides implantable receptacle devices (and methods) for use in bone and tissue regeneration which provide immediate structural stability and strength to a zone where tissue regeneration is required. By virtue of their size, shape and construction, the devices are scalable, modular, structurally stable, self-stacking in three dimensions, can be aggregated to an anatomically accurate shape, and hold various materials delivered into the implant area so as to create a highly regenerative micro-environment. They can be implanted via less invasive surgical procedures, and because they act as external scaffolding as well as being imbedded as an integral part of a matrix for the effective and rapid regeneration of bone and cartilage in vivo, they may provide significant advantages to patients or subjects in terms of reduced pain, faster healing and fewer complications.

Claims

1-25. -25. (canceled)

26. A self-stackable, tissue regenerating device comprising a receptacle, wherein the receptacle is polyhedral in shape, is meso-scale, micro-scale, or nano-scale, and is constructed from one or more solid, gelatinous, or viscous fluid biocompatible materials, wherein the one or more biocompatible materials form edges encompassing each polygonal face of the polyhedral shape.

27. The device of claim 26, wherein the polyhedral receptacle has a shape selected from the group consisting of a dodecahedron, a hexagonal prism, a hexagonal antiprism, a pentagonal dipyramid, and a tetrahedron.

28. The device of claim 26, wherein the device occupies a stable three dimensional volume and is not substantially deformed under biomechanical load within a range that is normal in a mammalian body and applied along multiple planes and axes.

29. The device of claim 26, wherein:

the interior of the receptacle is filled with the one or more biocompatible materials;

wherein the receptacle is partially enclosed, one or more of the polygonal faces of the polyhedral receptacle comprising the one or more biocompatible materials and the interior of the polyhedral receptacle being partially filled with the one or more biocompatible materials;

or

all of the polygonal faces of the polyhedral receptacle and the interior of the polyhedral receptacle being empty and all the edges of the polygonal faces comprising the one or more biocompatible materials.

30. The device of claim 29, wherein the one or more biocompatible materials is selected from the group consisting of metal, alloy, ceramic, or plastic.

31. The device of claim 29, wherein the one or more biocompatible materials are sintered and porous.

32. The device of claim 29, wherein the one or more biocompatible materials are coated or adsorbed with one or of antimicrobial peptides, antibiotics, biomolecules, biologics, or nanostructures.

33. The device of claim 26, wherein the polyhedral receptacle comprises an empty interior or an interior partially filled with the one or more biocompatible materials and the empty or partially filled interior comprises:

multiple finite compartments;

a small rod internally, a small plate internally;

a tenon protruding externally;

or a mortise recessed into the one or more biocompatible materials.

34. The device of claim 26, wherein the polyhedral receptacle is capable of

being unfolded, or partially unfolded, into a flat polygonal net, a flat polygonal plate, or any other shape resulting from the folding or unfolding of the net or plate;

or

being reversibly compressed.

35. The device of claim 26, further comprising, within the interior of the polyhedral receptacle, a biomimetic collagen construct.

36. The device of claim 35, wherein the device further comprises biofunctional cells.

37. The device of claim 36, wherein the biofunctional cells are one or more of fibroblasts, osteoclasts, osteocytes, chondrocytes, soft tissue cells, endothelial cells, blood cells, immune cells, or stem cells.

38. The device of claim 26, wherein the receptacle comprises a carrier for a slow-release drug, a delivery system for a slow-release drug, a medicament, one or more polymers, a glue, or one or more inorganic molecules.

39. The device of claim 26, wherein the device is one or more of:

nano-constructed, capable of nano-assembly;

capable of self-assembly;

or self-replicating.

40. A composite device comprising a plurality of devices, each device being the device of claim 26.

41. The composite device of claim 40, wherein the plurality of devices are assembled or aggregated in a three-dimensional conformation in which each polyhedral shape of each device has some or all of its polygonal faces contiguous with or aligned with at least one polygonal face of a polyhedral shape of another device.

42. The composite device of claim 41, wherein there are no spaces between the devices.

43. The composite device of claim 41, wherein there are spaces between the devices.

44. The composite device of claim 41, wherein the devices are dense packed in three dimensions.

45. The composite device of claim 44, wherein the interior of the receptacles are empty and, as a result, the composite device comprises a complex network of compartments in three dimensions, the network comprising a container.

46. The composite device of claim 40, further comprising an exterior hull surrounding the plurality of devices.

47. The composite device of claim 46, wherein the exterior hull comprises a resorbable polymer.

48. The composite device of claim 46, wherein the devices are embedded, packed, or stacked within niches or recesses in the interior surface of the exterior hull.

49. The composite device of claim 40, wherein the devices are of more than one shape.

50. A method of manufacturing a device, the method comprising:

providing a solid, gelatinous, or viscous fluid biocompatible material; and

manufacturing the device of claim 26 from the biocompatible material.

51. The method of claim 50, wherein the manufacturing comprises selective laser melting (SLM).

52. The method of claim 50, wherein the manufacturing comprises rapid prototyping.

53. The method of claim 50, wherein the manufacturing comprises solid fabrication, selective laser sintering (SLS), extrusion, nano-assembly, nano-construction, or gel formation followed by hardening.

54. The method of claim 50, further comprising incorporating within the interior space of the polyhedral shape, a biomimetic collagen construct.

55. The method of claim 54, further comprising seeding biologically functional cells into the devices.

56. The method of claim 55, wherein the seeding occurs prior to manufacture of the device, after manufacture of the device but prior to implantation into a mammalian subject, or after manufacture and implantation of the device into a mammalian subject.

57. The method of claim 54, further comprising incorporating into the devices one or more of the TGF-β

superfamily of ligands or one or more of BMP-1 family of proteases, the incorporating occurring prior to, or after, delivery of the device to a tissue in a mammalian subject.

58. A method of making a composite device, the method comprising:

providing a plurality of devices, each of which is the device of claim 26; and

assembling or aggregating the devices into a three dimensional conformation in which each polyhedral receptacle of each device has some or all of its polygonal faces contiguous with or aligned with at least one polygonal face of a polyhedral shape of another device.

59. The method of claim 58, wherein the assembly or aggregation occurs prior to delivery of the plurality of devices to a tissue in a mammalian subject.

60. The method of claim 58, wherein the assembly or aggregation occurs after delivery of the plurality of devices to a tissue in a mammalian subject.

61. A method of tissue regeneration, the method comprising:

providing a plurality of devices of claim 26; and

delivering the plurality of devices to a tissue in or on a mammalian subject, wherein the tissue is in need of regeneration.

62. The method of claim 61, wherein the plurality of devices are aggregated or assembled into a composite device prior to the delivery.

63. The method of claim 61, wherein the delivery comprises:

placing, projecting, pushing, driving, or embedding the plurality of devices directly into a tissue void;

infusing the plurality of devices in a discrete particulate flow through a catheter or channel;

introducing the plurality of devices into the body of the mammalian subject via the upper bowel, the lower bowel, the ureter, the urethra, or the vagina;

subcutaneous administration;

or

intravenous administration.

64. The method of claim 61, wherein the mammalian subject is a human.

65. The method of claim 61, wherein the devices provide immediate structural stability to the tissue.

66. The method of claim 61, wherein the devices form a stably supported and immobilized three dimensional matrix in the tissue after the delivery.

67. The method of claim 61, wherein the tissue comprises bone.

68. The method of claim 61, wherein the tissue comprises cartilage.

69. The method of claim 61, wherein any of unfolding, refolding, compression, or decompression of the devices occurs before, during, or after a procedure to deliver the devices to the tissue.

70. The method of claim 61, wherein biofunctional cells are seeded into the devices prior to the delivery.

71. The method of claim 61, wherein the devices are seeded in vivo with the biofunctional cells after the delivery.

72. A kit comprising one or more of the devices of claim 26.

73. The kit of claim 72, further comprising one or more surgical instruments or other equipment for promoting tissue regeneration in vivo.